|
MSH2 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 5.437800E-01 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.856430E-01 |
| Normal-vs-Stage2 |
3.151400E-01 |
| Normal-vs-Stage3 |
2.896400E-01 |
| Normal-vs-Stage4 |
6.904200E-01 |
| Stage1-vs-Stage2 |
9.938600E-01 |
| Stage1-vs-Stage3 |
5.057600E-02 |
| Stage1-vs-Stage4 |
8.831000E-01 |
| Stage2-vs-Stage3 |
1.159840E-01 |
| Stage2-vs-Stage4 |
8.751400E-01 |
| Stage3-vs-Stage4 |
3.186000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
5.301000E-01 |
| Normal-vs-AfricanAmerican |
4.292400E-01 |
| Normal-vs-Asian |
8.123600E-01 |
| Caucasian-vs-AfricanAmerican |
7.583400E-01 |
| Caucasian-vs-Asian |
9.682000E-01 |
| AfricanAmerican-vs-Asian |
8.729400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
2.218300E-02 |
| Normal-vs-Female |
5.558600E-03 |
| Male-vs-Female |
1.13079999997101E-06 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
8.072800E-01 |
| Normal-vs-Extreme_Weight |
4.294400E-02 |
| Normal-vs-Obese |
8.593400E-01 |
| Normal-vs-Extreme_Obese |
4.405700E-02 |
| Normal_Weight-vs-Extreme_Weight |
1.720410E-01 |
| Normal_Weight-vs-Obese |
7.115800E-01 |
| Normal_Weight-vs-Extreme_Obese |
2.438400E-01 |
| Extreme_Weight-vs-Obese |
4.576200E-02 |
| Extreme_Weight-vs-Extreme_Obese |
5.475000E-01 |
| Obese-vs-Extreme_Obese |
1.446190E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
2.043400E-01 |
| Normal-vs-Age(41-60Yrs) |
9.021400E-01 |
| Normal-vs-Age(61-80Yrs) |
1.223580E-01 |
| Normal-vs-Age(81-100Yrs) |
1.278200E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
1.329640E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
1.833920E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
5.323600E-02 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
7.279700E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
2.524400E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
7.099000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
9.675800E-02 |
| Normal-VS-Type2 PRCC |
4.635200E-01 |
| Normal-VS-KIRP CIMP |
2.440100E-02 |
| Normal-VS-Unclassified PRCC |
6.389600E-01 |
| Type1 PRCC-VS-Type2 PRCC |
4.835600E-01 |
| Type1 PRCC-VS-KIRP CIMP |
2.05500000000081E-05 |
| Type1 PRCC-VS-Unclassified PRCC |
7.567700E-02 |
| Type2 PRCC-VS-KIRP CIMP |
1.018720E-03 |
| Type2 PRCC-VS-Unclassified PRCC |
3.167600E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
1.321990E-02 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
6.097700E-02 |
| Normal-vs-N1 |
9.817600E-02 |
| Normal-vs-N2 |
7.951200E-01 |
| N0-vs-N1 |
1.004380E-02 |
| N0-vs-N2 |
2.454200E-01 |
| N1-vs-N2 |
6.736200E-01 |
|
|
